BC Cancer - Winter 2017 - 13

RIDE TO
CONQUER
CANCER
The BC Cancer Foundation's
Ride to Conquer Cancer,
presented by Wheaton
Precious Metals, is the
largest cancer fundraiser in
B.C. The event has raised an
incredible $85 million over
nine years to advance care for
people facing cancer across
our province. Join us for the
10th annual Ride to Conquer
Cancer happening August
25-26, 2018, as we embark
on a 200-kilometre cycling
journey from Vancouver to
Hope alongside thousands
of passionate individuals like
Rod. Visit conquercancer.ca.

Daryl's Heidelberg Hope team gathers after the 2017 Ride to Conquer Cancer.

It's worth us building on our incredible
expertise here at BC Cancer and bringing
this leading technology to British Columbians.

PROTRACER
CLINICAL TRIALS

- Rod Senft, who is honoring his late friend Daryl Clark
by supporting prostate cancer research

1

A phase II study of
177
Lu-PSMA-617 in 50
patients with metastatic
prostate cancer that
progressed after treatment
with drugs abiraterone and/or
enzalutamide.

introducing an emerging treatment
for aggressive prostate cancer into the
North American market."
With continued community support, including a $1 million investment
from an anonymous donor, BC Cancer
A phase I-II study
is well on its way to exploring effective
177
new prostate cancer treatments.
of Lu-PSMA-617
Two new clinical trials are planned
with docetaxel
to test whether ProTracer can eradichemotherapy in 50 patients
cate prostate cancer. It's good news for
with metastatic prostate
Rod, who says it's worth building on
cancer that progressed
the incredible expertise at BC Cancer
after treatment with
to bring this leading technology to
drugs abiraterone and/or
British Columbians.
enzalutamide.
The trials, which are expected to
span two years,
will be spearheaded by Dr.
RO RACER
François Bénard,
vice-president
By harnessing the power of radioof research at BC

2

BE PART OF P

T

pharmaceuticals, BC Cancer will
ﬁnd solutions. For more information, contact Alyson Meehan
at ameehan@bccancer.bc.ca
or 604.877.6160.

Cancer, and
Dr. Kim Chi,
clinical trials director,
in partnership with
colleagues
at TRIUMF,
Canada's
Dr. Kim Chi
national laboratory for particle
and nuclear physics at the University
of British Columbia.
Generous donors to the BC Cancer
Foundation have so far raised half
of the $4 million needed for these
groundbreaking trials.
"Philanthropy is essential in making ProTracer a reality for patients
facing the disease," Dr. Chi says. "It is
fantastic to see the community come
together to support this progress."

BCCANCERFOUNDATION.COM

13
http://www.conquercancer.ca http://www.BCCANCERFOUNDATION.COM
Table of Contents for the Digital Edition of BC Cancer - Winter 2017
